AIVAS Interactive Supercomputer Named Double Honoree for the 2025 CES Innovation Awards in Computer Hardware and Artificial Intelligence

Visit ALAFIA at the Supercomputing Conference, November 17-21 at the Georgia World Congress Center in Atlanta, for a live demonstration at SiliconANGLE Media, Inc.’s theCUBE Booth 3513

Supercomputing 2024: ALAFIA Introduces Suite of Personal Supercomputers to Power Critical Workflows & AI Applications for Precision Medicine & Clinical Environments

Maria Larrazabal
contact@alafia.ai
+1 341-222-9735

Alafia Ai, Inc. (“ALAFIA”), a leader in omics computing and precision medicine, is debuting today an expansion of its interactive high-performance computing (HPC) product line with more massively parallel computational capabilities, to meet the application developers and biopharmaceutical industry’s demand for scalable heterogenous computing. ALAFIA’s AIVAS, VIKI and GLADIS personal supercomputers offer low-latency, scalability, more compute density, and better power efficiency for mission critical and data intensive workloads, including AI training, inference and large language models (LLMs) workflows.

ALAFIA is delivering innovation to meet all these critical criteria by introducing an open configurable architecture with massively parallel heterogenous processors, including 128 to 512 Ampere® Arm CPU cores and over 47,000 NVIDIA CUDA-accelerated Graphical Processing Units (GPU) cores. Together with faster unified memory, each system includes increased addressable memory capacity of up to 8 terabytes (TB) and over 1,092 GB/s of memory bandwidth at over 9.6 Gbps (gigabits per second) or (9,600 MT/s) record speeds--allowing developers to easily interact with large language models with over 405 billion parameters at over 200 tokens per second. Making ALAFIA products more performant and capable than any AI PC available in the market. Designed and architected from the ground up to support use-cases from real time critical AI inference to molecular dynamics and protein design where compute and memory intensive applications can run smoothly locally, secured and encrypted on device.

“We know doctors, biotechnologist and pharmaceutical developers need optimized product options to meet their unique requirements which is why we created a family of products to meet their needs,” said Tillman Pearce, M.D., Chief Medical Officer, ALAFIA.

At the Supercomputing Conference (SC24) taking place November 17-21, ALAFIA will showcase GLADIS, the next generation all-in-one Interactive Supercomputer engineered for HPC developers and biopharmaceutical companies with 256 Ampere® Arm CPU cores, dual NVLinked NVIDIA H100 Tensor Core GPU and RTX 6000 Ada Generation Graphics Card with 47,359 NVIDIA CUDA-accelerated GPU cores with 236 GB of unified high-bandwidth memory and a whooping 4,096 GB (4 terabytes) of system memory. The system will be on display at theCube’s booth #3513.

Systems Architectures for Intelligent and Accelerated Future

ALAFIA has achieved an optimal architecture that harmoniously marries low-latency single threaded performance and high-throughput, massively parallel compute performance for the most demanding medical, scientific and high-performance computing use-cases. With an open architecture designed from the ground up to assist mathematical algorithms to remove noise from streams of data and increase numerical accuracy, ALAFIA is integrating software and hardware architecture technologies on behalf of customers to avoid unnecessary overhead and increase performance.

ALAFIA offers the industry's highest performance interactive supercomputers with maximum scalability by combining faster memory bandwidths and storage capacity with highly parallel computing capabilities, using 256 to 1024 next-generation machine learning (ML) single-instructions, multiple-data (SIMD) Ampere Arm CPU vectorization engines and artificial intelligence accelerators.

“We have supported ALAFIA since inception in their mission to speed the latest tools and algorithms coming out of medical research into the clinician’s hands, productizing them in a supercharged platform that moves decisions from overnight to minutes, from minutes to seconds,” said Joe Speed, Head of Edge, Ampere Computing.

Whether customers need maximum compute, memory bandwidth, storage capacity, or IO bandwidth, ALAFIA has the capacity to meet customer needs without compromising latency and interactivity for mission-critical applications by offering unparalleled precision, real-time data visualization and real-time processing.

AIVAS Named 2025 CES Innovation Award Honoree in Two Categories

ALAFIA’s introductory supercomputer AIVAS, has been named a double CES Innovation Awards 2025 Honoree by the Consumer Technology Association (CTA) in the Computer Hardware and Artificial Intelligence categories. AIVAS will be on display at CES 2025 in Las Vegas, January 7-10.

To see ALAFIA’s products and learn more please visit alafia.ai

About Alafia Ai, Inc. (“ALAFIA”)

ALAFIA provides a high-performance precision medicine platform designed to accelerate scientific and medical discoveries across hospitals, cancer and imaging centers, research institutions, pharmaceutical organizations, and biotechnology companies. Rooted in the belief that personalized care is fundamental to healthcare excellence, ALAFIA’s vision is to create an intelligent and adaptable healthcare ecosystem ensuring that every patient receives the highest standard of care.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241117750562/en/

“We know doctors, biotechnologist and pharmaceutical developers need optimized product options to meet their unique requirements which is why we created a family of products to meet their needs.” - Tillman Pearce, M.D., Chief Medical Officer, ALAFIA